Nanjing Pharmaceutical Co Ltd Class A 600713
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.93
- Day Range
- CNY 4.89–4.95
- 52-Week Range
- CNY 3.85–6.00
- Bid/Ask
- CNY 4.91 / CNY 4.92
- Market Cap
- CNY 6.45 Bil
- Volume/Avg
- 8.2 Mil / 9.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 10.84
- Price/Sales
- 0.12
- Dividend Yield (Trailing)
- 2.85%
- Dividend Yield (Forward)
- 2.85%
- Total Yield
- 2.85%
Company Profile
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Value
- Total Number of Employees
- 4,903
- Website
- http://www.guangyuyuan.com
Comparables
Valuation
Metric
|
600713
|
002424
|
600285
|
---|---|---|---|
Price/Earnings (Normalized) | 10.84 | 40.97 | 24.34 |
Price/Book Value | 0.98 | 2.03 | 4.89 |
Price/Sales | 0.12 | 1.53 | 4.17 |
Price/Cash Flow | 4.34 | — | 18.42 |
Price/Earnings
600713
002424
600285
Financial Strength
Metric
|
600713
|
002424
|
600285
|
---|---|---|---|
Quick Ratio | 1.07 | 0.77 | 1.02 |
Current Ratio | 1.41 | 1.10 | 1.33 |
Interest Coverage | 3.68 | — | — |
Quick Ratio
600713
002424
600285
Profitability
Metric
|
600713
|
002424
|
600285
|
---|---|---|---|
Return on Assets (Normalized) | 2.27% | −7.64% | 12.44% |
Return on Equity (Normalized) | 11.52% | −14.68% | 21.12% |
Return on Invested Capital (Normalized) | 6.36% | −9.95% | 19.26% |
Return on Assets
600713
002424
600285
Drug Manufacturers - General Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Wlkrflnqyv | Tyffg | $733.3 Bil | |
JNJ
| Johnson & Johnson | Jgxckcf | Rjwg | $360.8 Bil | |
MRK
| Merck & Co Inc | Hhwssrxk | Hffv | $329.8 Bil | |
ABBV
| AbbVie Inc | Hdjwwmb | Gnqyp | $283.3 Bil | |
AZN
| AstraZeneca PLC ADR | Pqvwsqpdb | Kwbv | $237.7 Bil | |
NVS
| Novartis AG ADR | Zjysfsnsd | Hhpkj | $203.4 Bil | |
RHHBY
| Roche Holding AG ADR | Ndtjdtzgxq | Pxzk | $197.6 Bil | |
AMGN
| Amgen Inc | Cypgwbbyt | Fbw | $166.4 Bil | |
PFE
| Pfizer Inc | Wlckbybj | Dbsb | $159.7 Bil | |
SNY
| Sanofi SA ADR | Jfptzhklv | Hyyw | $125.1 Bil |